Already a member?
Sign inBecome part of the foremost online community!
Sign Up NowOr, download the The Glaucoma Community app on your phone
American Academy of Ophthalmology and others
Learn about the latest glaucoma treatments and clinical studies, including new therapies in development and how research works.
If you’re living with glaucoma, you may wonder whether better treatments are coming. The answer is yes—but progress takes time. Today, most approved glaucoma treatments still focus on lowering eye pressure, which remains the best-proven way to slow vision loss. Doctors may use eye drops, laser treatment, minimally invasive glaucoma surgery, or traditional surgery, depending on your needs.
At the same time, researchers are studying new ways to make glaucoma care easier, longer-lasting, and more personalized. Some studies are testing improved eye drops. Others are looking at drug-releasing implants, surgical devices, home monitoring, diagnostic tools, and treatments that may protect the optic nerve itself.*
The biggest shift in glaucoma research is that scientists are not only asking, “How can we lower eye pressure?” They are also asking, “How can we make treatment easier to follow?” and “Can we better protect the optic nerve?”
That matters because glaucoma is usually a lifelong condition. Daily drops can be hard to use correctly and consistently. Some people have side effects, cost barriers, or trouble remembering doses. This is one reason sustained-release treatments (medicines that slowly release inside the eye over time) are a major area of study.
Another growing area is neuroprotection. This means trying to protect the optic nerve from damage. This is still an earlier research area, and there is no approved treatment that restores vision already lost from glaucoma. But it is an important direction because glaucoma damages the optic nerve, not just eye pressure numbers.
The studies below are current glaucoma studies (phase 2-4) listed on ClinicalTrials.gov with U.S. research locations. Some may also include sites outside the United States. Study details and recruitment status can change over time, so be sure to review each listing carefully and talk with your doctor about whether a study may be right for you.
Some studies are testing new or existing drops to see how well they lower eye pressure, how long they work, or how they compare with standard treatments.
This is one of the most active areas of glaucoma research. These treatments are designed to reduce the need for daily drops by slowly releasing medication inside the eye.
Some research focuses on improving how glaucoma procedures are performed or identifying which patients may benefit most.
Other studies are focused on improving how glaucoma is measured, monitored, or understood.
Some studies are exploring whether treatments can help support the optic nerve or preserve vision more directly.
Beyond pressure-lowering treatments, researchers are also exploring experimental gene and cell therapies that may one day help protect retinal cells affected by glaucoma. Companies including Astellas have publicly discussed early-stage glaucoma-related gene therapy research, though this work remains in preclinical development.
Clinical trials are research studies that test whether a treatment, device, procedure, or diagnostic tool is safe and useful. ClinicalTrials.gov is a public database where people can search for studies and learn about eligibility, locations, and contact information.
Every new treatment you hear about goes through a clinical trial process before becoming widely available.
In simple terms:
After a treatment is approved, Phase 4 studies may continue to track long-term safety and use. This process can take years, but it’s what ensures that treatments are both safe and effective.
Many of the therapies mentioned above went (or are going) through this exact process.
Clinical trials can be an option for some people, especially if:
Taking part in a trial is always voluntary. Before joining, you should be told what the study involves, what the possible risks and benefits are, how often visits are needed, and whether costs or travel support are available.
Good questions to ask include:
Clinical trials play an important role in advancing glaucoma research, but it’s important to verify information carefully before participating. Even trusted databases like ClinicalTrials.gov do not independently verify every detail included in a study listing.
Be cautious if a study:
Most reputable clinical trials:
Before joining a clinical trial, talk with your eye doctor. They can help you understand whether a study may be appropriate for your condition, treatment goals, and overall eye health.
Glaucoma research is moving in several directions at once. Some studies aim to make treatment easier by reducing the need for daily drops. Others focus on better surgery, improved monitoring, or protecting the optic nerve. A few are exploring bigger questions, such as whether future treatments could slow glaucoma in ways that go beyond eye pressure alone.
For now, the most important step is to keep working with your eye doctor and stay consistent with your current treatment plan. Research is moving forward, but it does not replace proven care today. The best approach is to stay informed, ask questions, and talk with your doctor if you are interested in clinical trials.
References:
The information provided by The Glaucoma Community is for educational purposes only and does not replace professional medical advice. Always talk with your healthcare provider before making changes to your treatment or care. The Glaucoma Community does not endorse specific treatments, providers, or products.
Source: {{articlecontent.article.sourceName}}
Receive daily updated expert-reviewed article summaries. Everything you need to know from discoveries, treatments, and living tips!
Already a Responsum member?
Available for Apple iOS and Android
We've sent a report to our community managers who will take the necessary steps. This member will be removed form your Community Chat and will no longer be able to message you.
Please contact us if you have any questions.
Add Comments
Cancel